North America Nanomedicine Market Research Report - Segmented By Product, Disease Type, Nano molecule Type and Country (the United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Trends and Growth Forecast (2024 to 2029)

Updated On: June, 2024
ID: 6248
Pages: 145

North America Nanomedicine Market Size (2024 to 2029)

The size of the Nanomedicine market in North America is valued at USD 77.42 billion in 2024. This value is projected to grow at a CAGR of 11.5% to reach USD 128.24 billion by 2029. The Global nanomedicine market was dominated by North America in 2023 and accounted for a market share of 42%.

The growing aging population in North America, Y-O-Y growth in the incidence of chronic diseases, particularly obesity, kidney disorders, cancer, diabetes, and orthopedic diseases, are majorly propelling the market growth. Growing funds and investments from governments and private organizations, and raising awareness regarding the Nanomedicine applications are likely to drive the market during the estimated period. Furthermore, the focus of key players on the R &D and wide range of Nanomedicine applications such as oncology, cardiovascular, neurology, anti-infective, and other areas are further fueling the Nanomedicine market in North America.

High costs associated with the Nanomedicine, lengthy approval process, and lack of knowledge regarding the Nanomedicine treatment options with this medicine are majorly restraining the market growth.

This research report on the North America Nanomedicine Market has been segmented and sub-segmented into the following categories.

North America Nanomedicine Market Analysis By Product

  • Diagnostic Imaging
  • Regenerative Medicine
  • Drug Deliver
  • Implants  
  • Vaccines  
  • Others

North America Nanomedicine Market Analysis By Disease Type

  • Cardiovascular Diseases    
  • Neurological Diseases        
  • Ophthalmological Diseases              
  • Infectious Diseases             
  • Immunological Diseases    
  • Orthopedic Disorders         
  • Oncological Diseases           
  • Others     

North America Nanomedicine Market Analysis By Nanomolecule Type

  • Nanotubes
  • Nanoparticles
  • Nanodevices
  • Nanoshells
  • Others

North America Nanomedicine Market Analysis By Country

  • The United States
  • Canada
  • Rest of North America

North America leads the Nanomedicine market due to the huge investments in nanomedicine research from government organizations in the United States. Due to the highly developed healthcare infrastructure and high incidence of cancer, nanomedicine is readily adopted.

The North America nanomedicine market is estimated to dominate by the U.S. during the forecast period due to the developing technology for drug delivery, growing acquisition for Nanomedicines, government steps taken towards enhancing healthcare facilities, and the insurance schemes are considered to fuel the market. Obtaining Nano-medicine in R&D activities of drugs for COVID-19 is expected to take the market growth to the next level in the coming years.

The Nanomedicine market for Canada is witnessed to have rapid growth over the analysis period due to Nanorobotics' existence, and these Nano-medicines are cost-effective. Enhancements over the biodegradable Nanoparticles growing applications like Nano-capsules and Nano-tubes for drug delivery systems, availability of skilled labor in manufacturing these drugs are expected to provide support for the market growth in Canada.

Companies playing a dominant role in the North America Nanomedicine Market profiled in this report are Johnson & Johnson, Merck & Co, Pfizer, Abbott Laboratories, GE Healthcare, Celgene Corporation, Nanosphere, Inc, Gilead Sciences, Hoffmann-La Roche, Nanospectra Biosciences, and Arrowhead Pharmaceuticals.

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample